Wedbush Securities’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Wedbush Securities’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-402,330	Closed	-$1.2M	–	1198
2022 Q1	$1.2M	Sell	402,330 -180,000	-31%	-$396K	0.06%	297
2021 Q4	$745K	Sell	582,330 -11,995	-2%	-$24K	0.03%	476
2021 Q3	$1.34M	Buy	594,325 +2,500	+0.4%	+$8.98K	0.06%	283
2021 Q2	$3.37M	Buy	591,825 +1,000	+0.2%	+$6.65K	0.16%	106
2021 Q1	$3.72M	Buy	590,825 +32,489	+6%	+$244K	0.21%	75
2020 Q4	$4.38M	Buy	+558,336	New	+$4.93M	0.38%	46

Wedbush Securities's TLMD Position: Q2 2022 in Review

Wedbush Securities sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 402,330 shares — an estimated $1.2M sold.

Wedbush Securities first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $4.38M in Q4 2020. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Wedbush Securities reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Wedbush Securities sold 402,330 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $1.2M.
Wedbush Securities first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
Wedbush Securities's SOC Telemed, Inc. Class A Common Stock position peaked at $4.38M in Q4 2020.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Wedbush Securities's 13F filing for Q2 2022, filed 21 Jul 2022.